{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Berberidaceae", "Berberis cretica", "HPLC-MS", "breast cancer", "isobolographic analysis", "isoquinoline alkaloids", "natural products", "palmatine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34684834", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "17"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "15"}], "Language": ["eng"], "ELocationID": ["6253", "10.3390/molecules26206253"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "20", "PubDate": {"Year": "2021", "Month": "Oct", "Day": "15"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Palmatine, a Bioactive Protoberberine Alkaloid Isolated from <i>Berberis cretica</i>, Inhibits the Growth of Human Estrogen Receptor-Positive Breast Cancer Cells and Acts Synergistically and Additively with Doxorubicin.", "Abstract": {"AbstractText": ["Palmatine (PLT) is a natural isoquinoline alkaloid that belongs to the class of protoberberines and exhibits a wide spectrum of pharmacological and biological properties, including anti-cancer activity. The aim of our study was to isolate PLT from the roots of <i>Berberis cretica</i> and investigate its cytotoxic and anti-proliferative effects in vitro alone and in combination with doxorubicine (DOX) using human ER<sup>+</sup>/HER2<sup>-</sup> breast cancer cell lines. The alkaloid was purified by column chromatography filled with silica gel NP and Sephadex LH-20 resin developed in the mixture of methanol: water (50:50 <i>v</i>/<i>v</i>) that provided high-purity alkaloid for bioactivity studies. The purity of the alkaloid was confirmed by high resolution mass measurement and MS/MS fragmentation analysis in the HPLC-ESI-QTOF-MS/MS-based analysis. It was found that PLT treatment inhibited the viability and proliferation of breast cancer cells in a dose-dependent manner as demonstrated by MTT and BrdU assays. PLT showed a quite similar growth inhibition on breast cancer cells with IC<sub>50</sub> values ranging from 5.126 to 5.805 \u00b5g/mL. In contrast, growth of normal human breast epithelial cells was not affected by PLT. The growth inhibitory activity of PLT was related to the induction of apoptosis, as determined by Annexin V/PI staining. Moreover, PLT sensitized breast cancer cells to DOX. Isobolographic analysis revealed synergistic and additive interactions between studied agents. Our studies suggest that PLT can be a potential candidate agent for preventing and treating breast cancer."]}, "AuthorList": [{"Identifier": ["0000-0002-3823-1467"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland."}], "LastName": "Grabarska", "ForeName": "Aneta", "Initials": "A"}, {"Identifier": ["0000-0002-7099-1968"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland."}], "LastName": "Wr\u00f3blewska-\u0141uczka", "ForeName": "Paula", "Initials": "P"}, {"Identifier": ["0000-0001-7076-600X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland."}], "LastName": "Kukula-Koch", "ForeName": "Wirginia", "Initials": "W"}, {"Identifier": ["0000-0002-3059-0393"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland."}], "LastName": "\u0141uszczki", "ForeName": "Jarogniew J", "Initials": "JJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pharmacognosy and Natural Products Chemistry, School of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupoli Zografou, 15771 Athens, Greece."}], "LastName": "Kalpoutzakis", "ForeName": "Eleftherios", "Initials": "E"}, {"Identifier": ["0000-0003-1677-7247"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Independent Medical Biology Unit, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland."}], "LastName": "Adamczuk", "ForeName": "Grzegorz", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pharmacognosy and Natural Products Chemistry, School of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupoli Zografou, 15771 Athens, Greece."}], "LastName": "Skaltsounis", "ForeName": "Alexios Leandros", "Initials": "AL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland."}], "LastName": "Stepulak", "ForeName": "Andrzej", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Berberine Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Estrogen"}, {"RegistryNumber": "19716-69-9", "NameOfSubstance": "protoberberine"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "G50C034217", "NameOfSubstance": "palmatine"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Berberine Alkaloids"}, {"QualifierName": ["chemistry"], "DescriptorName": "Berberis"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Roots"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Estrogen"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bray F., Ferlay J., Soerjomataram I., Siegel R., Torre L., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Dieci M., Orvieto E., Dominici M., Conte P., Guarneri V. Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities. Oncologist. 2014;19:805. doi: 10.1634/theoncologist.2014-0108.", "ArticleIdList": ["10.1634/theoncologist.2014-0108", "PMC4122475", "24969162"]}, {"Citation": "Viale G. The current state of breast cancer classification. Ann. Oncol. Off. J. Eur. Soc. Med Oncol. 2012;23((Suppl. 10)):x207\u2013x210. doi: 10.1093/annonc/mds326.", "ArticleIdList": ["10.1093/annonc/mds326", "22987963"]}, {"Citation": "Eliyatk\u0131n N., Yal\u00e7\u0131n E., Zengel B., Akta\u015f S., Vardar E. Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way. J. Breast Health. 2015;11:59. doi: 10.5152/tjbh.2015.1669.", "ArticleIdList": ["10.5152/tjbh.2015.1669", "PMC5351488", "28331693"]}, {"Citation": "Borin T., Angara K., Rashid M., Achyut B., Arbab A. Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis. Int. J. Mol. Sci. 2017;18:2661. doi: 10.3390/ijms18122661.", "ArticleIdList": ["10.3390/ijms18122661", "PMC5751263", "29292756"]}, {"Citation": "Lin Y., Zhang W., Cao H., Li G., Du W. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data. Genes. 2020;11:888. doi: 10.3390/genes11080888.", "ArticleIdList": ["10.3390/genes11080888", "PMC7464481", "32759821"]}, {"Citation": "Montemagno C., Pag\u00e8s G. Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine. Cancers. 2020;12:821. doi: 10.3390/cancers12040821.", "ArticleIdList": ["10.3390/cancers12040821", "PMC7226533", "32235331"]}, {"Citation": "He L., Lv Y., Song Y., Zhang B. The prognosis comparison of different molecular subtypes of breast tumors after radiotherapy and the intrinsic reasons for their distinct radiosensitivity. Cancer Manag. Res. 2019;11:5765. doi: 10.2147/CMAR.S213663.", "ArticleIdList": ["10.2147/CMAR.S213663", "PMC6612049", "31303789"]}, {"Citation": "Ferraiuolo R., Wagner K. Regulation and New Treatment Strategies in Breast Cancer. J. Life Sci. (Westlake Village Calif.) 2019;1:23. doi: 10.36069/JoLS/20191204.", "ArticleIdList": ["10.36069/JoLS/20191204", "PMC7039658", "32095785"]}, {"Citation": "Malenfant S., Eckmann K., Barnett C. Pertuzumab: A new targeted therapy for HER2-positive metastatic breast cancer. Pharmacotherapy. 2014;34:60\u201371. doi: 10.1002/phar.1338.", "ArticleIdList": ["10.1002/phar.1338", "23918291"]}, {"Citation": "Thorn C., Oshiro C., Marsh S., Hernandez-Boussard T., McLeod H., Klein T., Altman R. Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharm. Genom. 2011;21:440. doi: 10.1097/FPC.0b013e32833ffb56.", "ArticleIdList": ["10.1097/FPC.0b013e32833ffb56", "PMC3116111", "21048526"]}, {"Citation": "Trebunova M., Laputkova G., Slaba E., Lacjakova K., Verebova A. Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7. Anticancer. Res. 2012;32:2849\u20132854.", "ArticleIdList": ["22753747"]}, {"Citation": "Barzegar E., Fouladdel S., Movahhed T., Atashpour S., Ghahremani M., Ostad S., Azizi E. Effects of berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines. Iran. J. Basic Med. Sci. 2015;18:334.", "ArticleIdList": ["PMC4439447", "26019795"]}, {"Citation": "Nounou M., ElAmrawy F., Ahmed N., Abdelraouf K., Goda S., Syed-Sha-Qhattal H. Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies. Breast Cancer Basic Clin. Res. 2015;9:BCBCR-S29420. doi: 10.4137/BCBCR.S29420.", "ArticleIdList": ["10.4137/BCBCR.S29420", "PMC4589089", "26462242"]}, {"Citation": "Menna P., Salvatorelli E. Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview. Chemotherapy. 2017;62:159\u2013168. doi: 10.1159/000455823.", "ArticleIdList": ["10.1159/000455823", "28122377"]}, {"Citation": "Xu F., Wang F., Yang T., Sheng Y., Zhong T., Chen Y. Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells. Cancer Cell Int. 2014;14:1\u201313. doi: 10.1186/s12935-014-0142-4.", "ArticleIdList": ["10.1186/s12935-014-0142-4", "PMC4279688", "25550688"]}, {"Citation": "Talib W., Alsalahat I., Daoud S., Abutayeh R., Mahmod A. Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation. Molecules. 2020;25:5319. doi: 10.3390/molecules25225319.", "ArticleIdList": ["10.3390/molecules25225319", "PMC7696819", "33202681"]}, {"Citation": "Tarabasz D., Kukula-Koch W. Palmatine: A review of pharmacological properties and pharmacokinetics. Phytother. Res. PTR. 2020;34:33\u201350. doi: 10.1002/ptr.6504.", "ArticleIdList": ["10.1002/ptr.6504", "31496018"]}, {"Citation": "Ekeuku S., Pang K., Chin K. Palmatine as an Agent Against Metabolic Syndrome and Its Related Complications: A Review. Drug Des. Dev. Ther. 2020;14:4963. doi: 10.2147/DDDT.S280520.", "ArticleIdList": ["10.2147/DDDT.S280520", "PMC7680161", "33235437"]}, {"Citation": "Ortiz L., Lombardi P., Tillhon M., Scovassi A. Berberine, an epiphany against cancer. Molecules. 2014;19:12349\u201312367. doi: 10.3390/molecules190812349.", "ArticleIdList": ["10.3390/molecules190812349", "PMC6271598", "25153862"]}, {"Citation": "Johnson-Ajinwo O., Richardson A., Li W. Palmatine from Unexplored Rutideaparviflora Showed Cytotoxicity and Induction of Apoptosis in Human Ovarian Cancer Cells. Toxins. 2019;11:237. doi: 10.3390/toxins11040237.", "ArticleIdList": ["10.3390/toxins11040237", "PMC6521182", "31027283"]}, {"Citation": "Ali H., Dixit S. Extraction optimization of Tinosporacordifolia and assessment of the anticancer activity of its alkaloid palmatine. Sci. World J. 2013;2013:376216. doi: 10.1155/2013/376216.", "ArticleIdList": ["10.1155/2013/376216", "PMC3863568", "24379740"]}, {"Citation": "Fan T., Guo X., Zeng Q., Wei W., You X., Wang Y., Pang J., Song D. Synthesis and Structure-Activity Relationship of Palmatine Derivatives as a Novel Class of Antibacterial Agents against Helicobacter pylori. Molecules. 2020;25:1352. doi: 10.3390/molecules25061352.", "ArticleIdList": ["10.3390/molecules25061352", "PMC7146163", "32188132"]}, {"Citation": "Hambright H., Batth I., Xie J., Ghosh R., Kumar A. Palmatine inhibits growth and invasion in prostate cancer cell: Potential role for rpS6/NF\u03baB/FLIP. Mol. Carcinog. 2015;54:1227\u20131234. doi: 10.1002/mc.22192.", "ArticleIdList": ["10.1002/mc.22192", "PMC4490121", "25043857"]}, {"Citation": "Long J., Song J., Zhong L., Liao Y., Liu L., Li X. Palmatine: A review of its pharmacology, toxicity and pharmacokinetics. Biochimie. 2019;162:176\u2013184. doi: 10.1016/j.biochi.2019.04.008.", "ArticleIdList": ["10.1016/j.biochi.2019.04.008", "31051209"]}, {"Citation": "Kukula-Koch W., Aligiannis N., Halabalaki M., Skaltsounis A., Glowniak K., Kalpoutzakis E. Influence of extraction procedures on phenolic content and antioxidant activity of Cretan barberry herb. Food Chem. 2013;138:406\u2013413. doi: 10.1016/j.foodchem.2012.10.045.", "ArticleIdList": ["10.1016/j.foodchem.2012.10.045", "23265505"]}, {"Citation": "Okon E., Kukula-Koch W., Halasa M., Jarzab A., Baran M., Dmoszynska-Graniczka M., Angelis A., Kalpoutzakis E., Guz M., Stepulak A., et al. Magnoflorine-Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells. Biomolecules. 2020;10:1532. doi: 10.3390/biom10111532.", "ArticleIdList": ["10.3390/biom10111532", "PMC7696229", "33182753"]}, {"Citation": "Kukula-Koch W., Mroczek T. Application of hydrostatic CCC-TLC-HPLC-ESI-TOF-MS for the bioguided fractionation of anticholinesterase alkaloids from Argemonemexicana L. roots. Anal. Bioanal. Chem. 2015;407:2581\u20132589. doi: 10.1007/s00216-015-8468-x.", "ArticleIdList": ["10.1007/s00216-015-8468-x", "PMC4365284", "25618762"]}, {"Citation": "Kaja S., Payne A., Singh T., Ghuman J., Sieck E., Koulen P. An optimized lactate dehydrogenase release assay for screening of drug candidates in neuroscience. J. Pharmacol. Toxicol. Methods. 2015;73:1\u20136. doi: 10.1016/j.vascn.2015.02.001.", "ArticleIdList": ["10.1016/j.vascn.2015.02.001", "PMC4458191", "25681780"]}, {"Citation": "Litchfield J., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949;96:99\u2013113.", "ArticleIdList": ["18152921"]}, {"Citation": "Sung H., Ferlay J., Siegel R., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Shareef M., Ashraf M., Sarfraz M. Natural cures for breast cancer treatment. Saudi Pharm. J. 2016;24:233\u2013240. doi: 10.1016/j.jsps.2016.04.018.", "ArticleIdList": ["10.1016/j.jsps.2016.04.018", "PMC4881189", "27275107"]}, {"Citation": "Kooti W., Servatyari K., Behzadifar M., Asadi-Samani M., Sadeghi F., Nouri B., ZareMarzouni H. Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study. J. Evid. Based Complementary Altern. Med. 2017;22:982\u2013995. doi: 10.1177/2156587217696927.", "ArticleIdList": ["10.1177/2156587217696927", "PMC5871268", "28359161"]}, {"Citation": "McGrowder D., Miller F., Nwokocha C., Anderson M., Wilson-Clarke C., Vaz K., Anderson-Jackson L., Brown J. Medicinal Herbs Used in Traditional Management of Breast Cancer: Mechanisms of Action. Medicines. 2020;7:47. doi: 10.3390/medicines7080047.", "ArticleIdList": ["10.3390/medicines7080047", "PMC7460502", "32823812"]}, {"Citation": "Shin S., Moon S., Kim W., Paek S., Park H., Lee C. Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites. Int. J. Mol. Sci. 2018;19:2651. doi: 10.3390/ijms19092651.", "ArticleIdList": ["10.3390/ijms19092651", "PMC6163735", "30200668"]}, {"Citation": "Luo H., Vong C., Chen H., Gao Y., Lyu P., Qiu L., Zhao M., Liu Q., Cheng Z., Zou J., et al. Naturally occurring anti-cancer compounds: Shining from Chinese herbal medicine. Chin. Med. 2019;14:1\u201358. doi: 10.1186/s13020-019-0270-9.", "ArticleIdList": ["10.1186/s13020-019-0270-9", "PMC6836491", "31719837"]}, {"Citation": "Huang M., Lu J., Ding J. Natural Products in Cancer Therapy: Past, Present and Future. Nat. Prod. Bioprospect. 2021;11:5\u201313. doi: 10.1007/s13659-020-00293-7.", "ArticleIdList": ["10.1007/s13659-020-00293-7", "PMC7933288", "33389713"]}, {"Citation": "Kukula-Koch W., Kruk-S\u0142omka M., St\u0119pnik K., Szalak R., Bia\u0142a G. The Evaluation of Pro-Cognitive and Antiamnestic Properties of Berberine and Magnoflorine Isolated from Barberry Species by Centrifugal Partition Chromatography (CPC), in Relation to QSAR Modelling. Int. J. Mol. Sci. 2017;18:2511. doi: 10.3390/ijms18122511.", "ArticleIdList": ["10.3390/ijms18122511", "PMC5751114", "29186770"]}, {"Citation": "Mokhber-Dezfuli N., Saeidnia S., Gohari A., Kurepaz-Mahmoodabadi M. Phytochemistry and pharmacology of berberis species. Pharmacogn. Rev. 2014;8:8. doi: 10.4103/0973-7847.125517.", "ArticleIdList": ["10.4103/0973-7847.125517", "PMC3931204", "24600191"]}, {"Citation": "Belwal T., Bisht A., Devkota H., Ullah H., Khan H., Pandey A., Bhatt I., Echeverr\u00eda J. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases. Front. Pharmacol. 2020;11:41. doi: 10.3389/fphar.2020.00041.", "ArticleIdList": ["10.3389/fphar.2020.00041", "PMC7040237", "32132921"]}, {"Citation": "Kukula-Koch W. The Elevation of LC-ESI-Q-TOF-MS Response in the Analysis of Isoquinoline Alkaloids from Some Papaveraceae and Berberidaceae Representatives. J. Anal. Methods Chem. 2017;2017:8384107. doi: 10.1155/2017/8384107.", "ArticleIdList": ["10.1155/2017/8384107", "PMC5757148", "29435385"]}, {"Citation": "Gao Y., Wang F., Song Y., Liu H. The status of and trends in the pharmacology of berberine: A bibliometric review [1985\u20132018] Chin. Med. 2020;15:1\u201313. doi: 10.1186/s13020-020-0288-z.", "ArticleIdList": ["10.1186/s13020-020-0288-z", "PMC6971869", "31988653"]}, {"Citation": "Liu D., Meng X., Wu D., Qiu Z., Luo H. A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine. Front. Pharmacol. 2019;10 doi: 10.3389/fphar.2019.00009.", "ArticleIdList": ["10.3389/fphar.2019.00009", "PMC6382680", "30837865"]}, {"Citation": "Wang Y., Liu Y., Du X., Ma H., Yao J. The Anti-Cancer Mechanisms of Berberine: A Review. Cancer Manag. Res. 2020;12:695\u2013702. doi: 10.2147/CMAR.S242329.", "ArticleIdList": ["10.2147/CMAR.S242329", "PMC6996556", "32099466"]}, {"Citation": "Huang Q., Zhang W., Li Y., Chen J., Zhou B., Zou X., Zhang C., Cao Z. Alkaloid constituents from corydalis decumbens. J. China Pharm. Univ. 2017;48:563\u2013567."}, {"Citation": "Shi X., Li X., Zou M. Chemical constituents and biological activities of Stephania yunnanensis H. S. Lo. Biomed. Res. 2015;26:715\u2013720."}, {"Citation": "Wu J., Xiao Q., Zhang N., Xue C., Leung A., Zhang H., Tang Q., Xu C. Palmatine hydrochloride mediated photodynamic inactivation of breast cancer MCF-7 cells: Effectiveness and mechanism of action. Photodiagnosis Photodyn. Ther. 2016;15:133\u2013138. doi: 10.1016/j.pdpdt.2016.07.006.", "ArticleIdList": ["10.1016/j.pdpdt.2016.07.006", "27444887"]}, {"Citation": "Kissin I. An early indicator of drug success: Top Journal Selectivity Index. Drug Des. Dev. Ther. 2013;7:93\u201398. doi: 10.2147/DDDT.S37324.", "ArticleIdList": ["10.2147/DDDT.S37324", "PMC3575128", "23430968"]}, {"Citation": "Pe\u00f1a-Mor\u00e1n O., Villarreal M., \u00c1lvarez-Berber L., Meneses-Acosta A., Rodr\u00edguez-L\u00f3pez V. Cytotoxicity, Post-Treatment Recovery, and Selectivity Analysis of Naturally Occurring Podophyllotoxins from Bursera fagaroides var. fagaroides on Breast Cancer Cell Lines. Molecules. 2016;21:1013. doi: 10.3390/molecules21081013.", "ArticleIdList": ["10.3390/molecules21081013", "PMC6274026", "27527135"]}, {"Citation": "Ogbole O., Segun P., Adeniji A. In vitro cytotoxic activity of medicinal plants from Nigeria ethnomedicine on Rhabdomyosarcoma cancer cell line and HPLC analysis of active extracts. BMC Complementary Altern. Med. 2017;17:494. doi: 10.1186/s12906-017-2005-8.", "ArticleIdList": ["10.1186/s12906-017-2005-8", "PMC5700537", "29166892"]}, {"Citation": "Oluyemisi O., Oriabure A., Adekunle A., Ramsay K., Shyyaula S., Choudhary M. Bioassay-guided isolation of Poliovirus-inhibiting constituents from Zephyranthes candida. Pharm. Biol. 2015;53:882\u2013887. doi: 10.3109/13880209.2014.946061.", "ArticleIdList": ["10.3109/13880209.2014.946061", "25431196"]}, {"Citation": "K\u0159\u00ed\u017ekovsk\u00e1 B., Kumar R., \u0158eho\u0159ov\u00e1 K., S\u00fdkora D., Dobiasov\u00e1 S., Ku\u010derov\u00e1 D., Tan M., Linis V., Oyong G., Ruml T., et al. Comparison of Chemical Composition and Biological Activities of Eight Selaginella Species. Pharmaceuticals. 2020;14:16. doi: 10.3390/ph14010016.", "ArticleIdList": ["10.3390/ph14010016", "PMC7823444", "33375355"]}, {"Citation": "Indrayanto G., Putra G., Suhud F. Chapter Six\u2014Validation of In-Vitro Bioassay Methods: Application in Herbal Drug Research. Volume 46 Academic Press; Cambridge, MA, USA: 2021.", "ArticleIdList": ["33461699"]}, {"Citation": "Erhirhie E., Ihekwereme C., Ilodigwe E. Advances in acute toxicity testing: Strengths, weaknesses and regulatory acceptance. Interdiscip. Toxicol. 2018;11:5\u201312. doi: 10.2478/intox-2018-0001.", "ArticleIdList": ["10.2478/intox-2018-0001", "PMC6117820", "30181707"]}, {"Citation": "Yi J., Ye X., Wang D., He K., Yang Y., Liu X., Li X. Safety evaluation of main alkaloids from RhizomaCoptidis. J. Ethnopharmacol. 2013;145:303\u2013310. doi: 10.1016/j.jep.2012.10.062.", "ArticleIdList": ["10.1016/j.jep.2012.10.062", "23159469"]}, {"Citation": "Ma W., Li H., Dong C., He X., Guo C., Zhang C., Yu C., Wang C., Yuan C. Palmatine from Mahonia bealei attenuates gut tumorigenesis in ApcMin/+ mice via inhibition of inflammatory cytokines. Mol. Med. Rep. 2016;14:491\u2013498. doi: 10.3892/mmr.2016.5285.", "ArticleIdList": ["10.3892/mmr.2016.5285", "PMC4918606", "27175745"]}, {"Citation": "Zheng X., Wu F., Lin X., Shen L., Feng Y. Developments in drug delivery of bioactive alkaloids derived from traditional Chinese medicine. Drug Deliv. 2018;25:398\u2013416. doi: 10.1080/10717544.2018.1431980.", "ArticleIdList": ["10.1080/10717544.2018.1431980", "PMC6058676", "29378456"]}, {"Citation": "Cui H., Zhang Q., Wang J., Chen J., Zhang Y., Tong X. Poor permeability and absorption affect the activity of four alkaloids from Coptis. Mol. Med. Rep. 2015;12:7160\u20137168. doi: 10.3892/mmr.2015.4288.", "ArticleIdList": ["10.3892/mmr.2015.4288", "26352530"]}, {"Citation": "Habtemariam S. Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization. Molecules. 2020;25:1426. doi: 10.3390/molecules25061426.", "ArticleIdList": ["10.3390/molecules25061426", "PMC7144379", "32245062"]}, {"Citation": "BayatMokhtari R., Homayouni T., Baluch N., Morgatskaya E., Kumar S., Das B., Yeger H. Combination therapy in combating cancer. Oncotarget. 2017;8:38022\u201338043. doi: 10.18632/oncotarget.16723.", "ArticleIdList": ["10.18632/oncotarget.16723", "PMC5514969", "28410237"]}, {"Citation": "Zhang Y., Li H., Zhang J., Zhao C., Lu S., Qiao J., Han M. The combinatory effects of natural products and chemotherapy drugs and their mechanisms in breast cancer treatment. Phytochem. Rev. 2020;19:1179\u20131197. doi: 10.1007/s11101-019-09628-w.", "ArticleIdList": ["10.1007/s11101-019-09628-w"]}, {"Citation": "Chakravarthy D., Mu\u00f1oz A., Su A., Hwang R., Keppler B., Chan D., Halff G., Ghosh R., Kumar A. Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. Cancer Lett. 2018;419:103\u2013115. doi: 10.1016/j.canlet.2018.01.057.", "ArticleIdList": ["10.1016/j.canlet.2018.01.057", "PMC5858579", "29414301"]}, {"Citation": "Lipinska N., Romaniuk A., Paszel-Jaworska A., Toton E., Kopczynski P., Rubis B. Telomerase and drug resistance in cancer. Cell. Mol. Life Sci. CMLS. 2017;74:4121\u20134132. doi: 10.1007/s00018-017-2573-2.", "ArticleIdList": ["10.1007/s00018-017-2573-2", "PMC5641272", "28623509"]}, {"Citation": "Ji X., Sun H., Zhou H., Xiang J., Tang Y., Zhao C. The interaction of telomeric DNA and C-myc22 G-quadruplex with 11 natural alkaloids. Nucleic Acid Ther. 2012;22:127\u2013136. doi: 10.1089/nat.2012.0342.", "ArticleIdList": ["10.1089/nat.2012.0342", "PMC3317788", "22480315"]}, {"Citation": "Chen Y., Zhang Y. Functional and mechanistic analysis of telomerase: An antitumor drug target. Pharmacol. Ther. 2016;163:24\u201347. doi: 10.1016/j.pharmthera.2016.03.017.", "ArticleIdList": ["10.1016/j.pharmthera.2016.03.017", "27118336"]}, {"Citation": "Awadasseid A., Ma X., Wu Y., Zhang W. G-quadruplex stabilization via small-molecules as a potential anti-cancer strategy. Biomed. Pharmacother. 2021;139:111550. doi: 10.1016/j.biopha.2021.111550.", "ArticleIdList": ["10.1016/j.biopha.2021.111550", "33831835"]}, {"Citation": "Pfeffer C., Singh A. Apoptosis: A Target for Anticancer Therapy. Int. J. Mol. Sci. 2018;19:448. doi: 10.3390/ijms19020448.", "ArticleIdList": ["10.3390/ijms19020448", "PMC5855670", "29393886"]}, {"Citation": "Liu X., Zhang Y., Wu S., Xu M., Shen Y., Yu M., Fan J., Wei S., Xu C., Huang L., et al. Palmatine induces G2/M phase arrest and mitochondrial-associated pathway apoptosis in colon cancer cells by targeting AURKA. Biochem. Pharmacol. 2020;175:113933. doi: 10.1016/j.bcp.2020.113933.", "ArticleIdList": ["10.1016/j.bcp.2020.113933", "32224138"]}, {"Citation": "Dai X., Cheng H., Bai Z., Li J. Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping. J. Cancer. 2017;8:3131\u20133141. doi: 10.7150/jca.18457.", "ArticleIdList": ["10.7150/jca.18457", "PMC5665029", "29158785"]}, {"Citation": "Kim M., Choi J., Tae N., Wi T., Kim K., Kim D., Lee E. Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells. Int. J. Mol. Sci. 2020;21:3258. doi: 10.3390/ijms21093258.", "ArticleIdList": ["10.3390/ijms21093258", "PMC7247325", "32380650"]}, {"Citation": "Luszczki J. Isobolographic analysis of interaction between drugs with nonparallel dose-response relationship curves: A practical application. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2007;375:105\u2013114. doi: 10.1007/s00210-007-0144-z.", "ArticleIdList": ["10.1007/s00210-007-0144-z", "17333129"]}, {"Citation": "Luszczki J., Czuczwar S. Isobolographic profile of interactions between tiagabine and gabapentin: A preclinical study. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2004;369:434\u2013446. doi: 10.1007/s00210-004-0867-z.", "ArticleIdList": ["10.1007/s00210-004-0867-z", "14985937"]}, {"Citation": "Luszczki J., Czuczwar S. Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: A three-dimensional isobolographic analysis. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2006;374:51\u201364. doi: 10.1007/s00210-006-0100-3.", "ArticleIdList": ["10.1007/s00210-006-0100-3", "16972063"]}, {"Citation": "Grabovsky Y., Tallarida R. Isobolographic analysis for combinations of a full and partial agonist: Curved isoboles. J. Pharmacol. Exp. Ther. 2004;310:981\u2013986. doi: 10.1124/jpet.104.067264.", "ArticleIdList": ["10.1124/jpet.104.067264", "15175417"]}, {"Citation": "Tallarida R. An overview of drug combination analysis with isobolograms. J. Pharmacol. Exp. Ther. 2006;319:1\u20137. doi: 10.1124/jpet.106.104117.", "ArticleIdList": ["10.1124/jpet.106.104117", "16670349"]}, {"Citation": "Tallarida R. Interactions between drugs and occupied receptors. Pharmacol. Ther. 2007;113:197\u2013209. doi: 10.1016/j.pharmthera.2006.08.002.", "ArticleIdList": ["10.1016/j.pharmthera.2006.08.002", "PMC2045509", "17079019"]}, {"Citation": "Tallarida R. Drug Combinations: Tests and Analysis with Isoboles. Curr. Protoc. Pharmacol. 2016;72:9.19.1\u20139.19.19. doi: 10.1002/0471141755.ph0919s72.", "ArticleIdList": ["10.1002/0471141755.ph0919s72", "PMC4839184", "26995550"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "2"}, {"Year": "2021", "Month": "10", "Day": "1"}, {"Year": "2021", "Month": "10", "Day": "8"}, {"Year": "2021", "Month": "10", "Day": "23", "Hour": "1", "Minute": "19"}, {"Year": "2021", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["34684834", "PMC8538708", "10.3390/molecules26206253", "molecules26206253"]}}], "PubmedBookArticle": []}